273 related articles for article (PubMed ID: 9466352)
1. Bakkenolide G, a natural PAF-receptor antagonist.
Liao CH; Ko FN; Wu TS; Teng CM
J Pharm Pharmacol; 1997 Dec; 49(12):1248-53. PubMed ID: 9466352
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
Liao CH; Ko FN; Wu CL; Teng CM
J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM
Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet actions of some coumarin compounds isolated from plant sources.
Teng CM; Li HL; Wu TS; Huang SC; Huang TF
Thromb Res; 1992 Jun; 66(5):549-57. PubMed ID: 1523611
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
Ding YA; Chou TC; Chern JW; Yen MH
Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet action of 3',4'-diisovalerylkhellactone diester purified from Peucedanum japonicum Thunb.
Hsiao G; Ko FN; Jong TT; Teng CM
Biol Pharm Bull; 1998 Jul; 21(7):688-92. PubMed ID: 9703250
[TBL] [Abstract][Full Text] [Related]
8. PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr.
Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
Eur J Pharmacol; 1992 Jul; 218(1):129-35. PubMed ID: 1327822
[TBL] [Abstract][Full Text] [Related]
9. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.
Ko FN; Yu SM; Chen IS; Ishii H; Chang YL; Huang TF; Teng CM
Biochim Biophys Acta; 1993 Jan; 1175(2):225-31. PubMed ID: 8380343
[TBL] [Abstract][Full Text] [Related]
10. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
[TBL] [Abstract][Full Text] [Related]
11. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
[TBL] [Abstract][Full Text] [Related]
12. The effect of 3-[2-(cyclopropylamino)ethoxy]xanthone on platelet thromboxane formation.
Chen WY; Ko FN; Lin CN; Teng CM
Thromb Res; 1994 Jul; 75(1):81-90. PubMed ID: 8073410
[TBL] [Abstract][Full Text] [Related]
13. Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies.
Castro-Faria-Neto HC; Bozza PT; Cruz HN; Silva CL; Violante FA; Barbosa-Filho JM; Thomas G; Martins MA; Tibiriçá EV; Noel F
Planta Med; 1995 Apr; 61(2):101-5. PubMed ID: 7753913
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation.
Ko FN; Yeh LJ; Liang HC; Kuo SC; Teng CM
J Pharm Pharmacol; 1996 Apr; 48(4):395-400. PubMed ID: 8794990
[TBL] [Abstract][Full Text] [Related]
15. Effects of tetrandrine and fangchinoline on human platelet aggregation and thromboxane B2 formation.
Kim HS; Zhang YH; Fang LH; Yun YP; Lee HK
J Ethnopharmacol; 1999 Aug; 66(2):241-6. PubMed ID: 10433485
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
17. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
19. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man.
Teng CM; Hsueh CM; Chang YL; Ko FN; Lee SS; Liu KC
J Pharm Pharmacol; 1997 Jul; 49(7):706-11. PubMed ID: 9255715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
